Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Seroepidemiology
100%
Influenza
81%
Europe
65%
Respiratory Syncytial Virus
60%
Wales
49%
Influenza Season
47%
Age Groups
43%
European Countries
41%
Mumps
38%
Western Europe
35%
Pertussis
33%
Vaccine Effectiveness
33%
World Health Organization
32%
United Kingdom
32%
Vaccination
30%
Influenza Vaccination
30%
Rubella
25%
Virus Surveillance
25%
Hospital Admission
25%
Excess Mortality
24%
Surveillance Data
23%
H3N2 Virus
22%
Seasonal Influenza
22%
Rotavirus
21%
Serosurvey
21%
European Economic Area
21%
European Union
21%
Vaccination Coverage
20%
Measles-mumps-rubella
20%
Disease Burden
20%
Measles
19%
Israel
19%
Surveillance System
19%
Pertussis Toxin
19%
European Regions
19%
Netherlands
18%
A(H1N1)pdm09
18%
Seroprevalence
18%
Titre
17%
Infectious Diseases
17%
Influenza Surveillance
17%
Influenza Vaccine Effectiveness
16%
Travellers
16%
Conjugate Vaccine
16%
Influenza A(H3N2)
16%
Number of Deaths
16%
Surveillance Studies
16%
Public Health
16%
Epidemiology
16%
Respiratory Infection
16%
Disease Incidence
16%
Disease Control
15%
Virus
15%
Influenza A
15%
Influenza Virus
14%
Respiratory Pathogens
14%
Mumps Outbreak
14%
Disease Case
14%
WHO European Region
14%
Serum Samples
13%
Virus Circulation
13%
Influenza Activity
13%
Australia
13%
Age-specific
12%
Severe Influenza
12%
Web Platform
12%
Public Health Authorities
12%
Older Adults
12%
Vaccination Program
12%
Hospitalization
11%
Vaccinated Individuals
11%
Italy
11%
Immunization Programs
11%
Primary Care
11%
Sweden
11%
High Susceptibility
11%
Avian Influenza
11%
Vaccination Campaign
11%
Incidence Data
11%
COVID-19
11%
Rotavirus Vaccine
10%
Healthcare Workers
10%
Live Attenuated Influenza Vaccine
10%
Influenza Vaccine
10%
Norovirus
10%
Seropositivity
10%
Potential Risk
10%
Pre-vaccination
10%
Sentinel System
10%
Health Care Services
10%
Young Female
10%
Streptococcus Pneumoniae
10%
Rotavirus Infection
10%
All Ages
9%
Virus-neutralizing Antibodies
9%
Susceptibility Level
9%
Vaccine Strain
9%
Influenza A(H1N1)pdm09 Virus
9%
Sentinel Network
9%
Acute Respiratory Infection
9%
Medicine and Dentistry
Influenza
56%
Infection
45%
Diseases
38%
Seroepidemiology
35%
Pertussis
33%
Mumps
25%
Public Health
23%
Influenza Vaccination
22%
Influenza Vaccine
22%
Seasonal Influenza
19%
Age Groups
19%
Decision Making
17%
Rubella
16%
Measles
16%
COVID-19
16%
Respiratory Tract Infection
15%
Virus
15%
Pathogen
14%
Pertussis Toxin
14%
Human Respiratory Syncytial Virus
13%
Cohort Effect
13%
Adolescence
12%
Primary Health Care
11%
High Risk Population
11%
Cross Sectional Study
11%
Influenza A
11%
Avian Influenza
11%
Vaccination Coverage
9%
Health Care Personnel
9%
Enzyme Linked Immunosorbent Assay
9%
Influenza A Virus (H3N2)
8%
Virus Surveillance
8%
Influenza A Virus (H1N1)
8%
Conjugate Vaccine
8%
Systematic Review
8%
Telehealth
8%
Reproductive Medicine
8%
Drug Uptake
8%
Spatiotemporal Analysis
8%
Disease Epidemiology
8%
Vaccine Efficacy
8%
Group Structure
8%
Rotavirus
8%
Rotavirus Infection
8%
Pontiac Fever
8%
Pneumococcal Infection
8%
Etiology
8%
Burkholderia stabilis
8%
Microcephaly
8%
Severe Acute Respiratory Syndrome Coronavirus 2
8%
Norovirus
8%
Enteropathy
8%
Influenza A Virus (H5N8)
8%
Immunoassay
8%
Clinical Trial
8%
Mortality Rate
7%
National Health Service
6%
Respiratory Disease
6%
Pregnant Woman
5%
Norovirus Infection
5%
Returning Traveler
5%
Disease Burden
5%
Coughing
5%
Incident Management
5%